2-bromopalmitate has been researched along with Breast Cancer in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chan, LC; Hou, J; Hsu, JL; Hsu, JM; Hung, MC; Li, CW; Qiu, Y; Sun, L; Wei, Y; Xia, W; Yang, Y | 1 |
Fox, T; Heakal, Y; Kester, M; Levenson, R; Seaton, K; Woll, MP | 1 |
2 other study(ies) available for 2-bromopalmitate and Breast Cancer
Article | Year |
---|---|
Palmitoylation stabilizes PD-L1 to promote breast tumor growth.
Topics: Acyltransferases; Adenocarcinoma; Animals; B7-H1 Antigen; Biomarkers, Tumor; Breast Neoplasms; Cell Line, Tumor; Female; HEK293 Cells; Humans; Lipoylation; Mice; Mice, Inbred BALB C; Palmitates; Prognosis; Protein Stability | 2019 |
Neurotensin receptor-1 inducible palmitoylation is required for efficient receptor-mediated mitogenic-signaling within structured membrane microdomains.
Topics: Apoptosis; Breast Neoplasms; Cell Line; Cell Membrane; Extracellular Signal-Regulated MAP Kinases; Female; Glycosylation; GTP-Binding Protein alpha Subunits, Gq-G11; Humans; Lipoylation; MAP Kinase Signaling System; Mutagenesis, Site-Directed; Neurotensin; Palmitates; Phosphorylation; Receptors, Mitogen; Receptors, Neurotensin; Tunicamycin | 2011 |